Abnormal shifts in the composition of gut microbiota contribute to the pathogenesis of
metabolic diseases, including obesity and type 2 diabetes (T2DM). The crosstalk between …

Obesity and type 2 diabetes are characterized by altered gut microbiota, inflammation, and
gut barrier disruption. Microbial composition and the mechanisms of interaction with the host …

Recent evidence indicates that the gut microbiota plays a key role in the pathophysiology of
obesity. Indeed, diet-induced obesity (DIO) has been associated to substantial changes in …

Obesity and its metabolic syndrome, including liver disorders and type 2 diabetes, are a
worldwide epidemic and are intimately linked to diet. The gut microbiota interaction has …

Recently, Akkermansia muciniphila an anaerobic member of the gut microbiota, has been
proposed as a next-generation probiotic. The aim of this study was evaluation of the effect of …

Akkermansia muciniphila is a mucosal symbiont considered a gut microbial marker in
healthy individuals, as its relative abundance is significantly reduced in subjects with gut …

The gut microbiota, which includes Akkermansia muciniphila, is known to modulate energy
metabolism, glucose tolerance, immune system maturation and function in humans …

Akkermansia muciniphila is a Gram-negative anaerobic mucus-layer-degrading bacterium
that colonizes the intestinal mucosa of humans and rodents. Metagenomic data have shown …

Recent evidence suggests that probiotics can restore the mucosal barrier integrity,
ameliorate inflammation, and promote homeostasis required for metabolism in obesity by …

Growing evidence indicates that the gut microbiota plays a significant role in the
pathophysiological processes of obesity and its related metabolic symptoms in the host …